2022年美国风湿病学会/欧洲抗风湿病联盟大动脉炎分类标准的验证
本研究在四个转诊中心验证2022年ACR/EULAR大动脉炎分类标准,与1990年ACR标准比较。在504例大动脉炎和222例对照(含144例颅外巨细胞动脉炎)中,2022标准敏感性更高(95.83% vs 82.94%)但特异性更低(63.51% vs 90.54%)。将cut-off提高至6或7分,或去除女性性别分值,可改善敏感性与特异性的平衡。
要点
- 2022年ACR/EULAR标准敏感性95.83%高于1990年ACR标准的82.94%,但特异性63.51%低于90.54%。
- 将cut-off提高至≥6分(敏感性91.87%,特异性82.88%)或≥7分(敏感性86.71%,特异性86.49%)可改善平衡。
- 去除女性性别分值后敏感性92.64%、特异性81.08%。
核心结论
- 2022年ACR/EULAR大动脉炎分类标准在真实临床环境中特异性较差,通过提高cut-off至6或7分或去除女性性别分值可改善。
研究设计与样本
- 研究评估了四个转诊中心的大动脉炎患者与颅外巨细胞动脉炎及其他对照,比较2022年ACR/EULAR与1990年ACR分类标准的符合情况。
主要发现
- 在504例大动脉炎患者(404例女性)和222例对照(151例女性,144例颅外巨细胞动脉炎)中,2022年ACR/EULAR标准在预设cut-off下敏感性(95.83% vs 82.94%)和阴性预测值优于1990年ACR标准,但特异性(63.51% vs 90.54%)、阳性预测值、阳性似然比、阴性似然比和AUC较差。
- 2022年ACR/EULAR标准在男性中特异性(76.06% vs 57.62%)和AUC(0.845 vs 0.771)高于女性,敏感性相似(93% vs 96.53%)。
- 仅以颅外巨细胞动脉炎为对照时,2022年ACR/EULAR标准敏感性95.83%、特异性60.42%、AUC 0.781。
- 40-60岁相比<40岁敏感性相似,特异性更高。
- cut-off≥6分时敏感性91.87%、特异性82.88%;cut-off≥7分时敏感性86.71%、特异性86.49%;去除女性性别分值后敏感性92.64%、特异性81.08%。
关键数值与推荐
- 2022年ACR/EULAR标准在预设cut-off下敏感性95.83%、特异性63.51%、AUC未报告具体数值。
- 1990年ACR标准敏感性82.94%、特异性90.54%。
- cut-off≥6分:敏感性91.87%、特异性82.88%。
- cut-off≥7分:敏感性86.71%、特异性86.49%。
- 去除女性性别分值:敏感性92.64%、特异性81.08%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The present study validates the 2022 ACR/European Alliance of Associations for Rheumatology (EULAR) classification criteria for Takayasu's arteritis (TAK), compared with the 1990 ACR TAK classification criteria. METHODS: The fulfilment of 2022 ACR/EULAR and 1990 ACR TAK criteria from four referral centres was assessed for TAK compared with extracranial giant cell arteritis (EC-GCA) and other controls. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), likelihood ratio of a positive test (LR+) or negative test (LR-), and area under receiver operating characteristics curve (AUC) were calculated. RESULTS: Among 504 patients with TAK (404 females) and 222 controls (151 females, 144 patients with EC-GCA), the 2022 ACR/EULAR criteria had better sensitivity (95.83% vs 82.94%) and NPV, but poorer specificity (63.51% vs 90.54%), PPV, LR+, LR- and AUC at the pre-determined cut-offs than the 1990 ACR criteria. The 2022 ACR/EULAR criteria had greater specificity (76.06% vs 57.62%) and AUC (0.845 vs 0.771), with similar sensitivity (93% vs 96.53%) in males as in females. The 2022 ACR/EULAR criteria performed similarly with only EC-GCA as controls (sensitivity 95.83%, specificity 60.42%, AUC 0.781). Sensitivity remained similar, whereas specificity was higher for 40-60 years vs <40 years. Cut-offs of ≥6 (sensitivity 91.87%, specificity 82.88%) and ≥7 (sensitivity 86.71%, specificity 86.49%), or removing the point for female sex (sensitivity 92.64%, specificity 81.08%) greatly improved the balance between sensitivity and specificity. CONCLUSION: The poor specificity of the 2022 ACR/EULAR TAK criteria in real-life settings was improved by increasing the cut-off to 6 or 7, or removing the point for female sex.
引用
- Tomelleri A, Padoan R, Kavadichanda CG, et al. Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Rheumatology (Oxford). 2023. PMID: 37018125. doi:10.1093/rheumatology/kead161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。